
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation
Jae‐Sook Ahn, Hyeoung‐Joon Kim, Yeo‐Kyeoung Kim, et al.
Biology of Blood and Marrow Transplantation (2015) Vol. 22, Iss. 1, pp. 61-70
Open Access | Times Cited: 54
Jae‐Sook Ahn, Hyeoung‐Joon Kim, Yeo‐Kyeoung Kim, et al.
Biology of Blood and Marrow Transplantation (2015) Vol. 22, Iss. 1, pp. 61-70
Open Access | Times Cited: 54
Showing 1-25 of 54 citing articles:
DNMT3A in Leukemia
Lorenzo Brunetti, Michael C. Gundry, Margaret A. Goodell
Cold Spring Harbor Perspectives in Medicine (2016) Vol. 7, Iss. 2, pp. a030320-a030320
Open Access | Times Cited: 170
Lorenzo Brunetti, Michael C. Gundry, Margaret A. Goodell
Cold Spring Harbor Perspectives in Medicine (2016) Vol. 7, Iss. 2, pp. a030320-a030320
Open Access | Times Cited: 170
Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies
Ailin Zhao, Hui Zhou, Jinrong Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 64
Ailin Zhao, Hui Zhou, Jinrong Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 64
Oncogenic Roles and Inhibitors of DNMT1, DNMT3A, and DNMT3B in Acute Myeloid Leukaemia
Kah Keng Wong, Charles H. Lawrie, Tina M. Green
Biomarker Insights (2019) Vol. 14
Open Access | Times Cited: 110
Kah Keng Wong, Charles H. Lawrie, Tina M. Green
Biomarker Insights (2019) Vol. 14
Open Access | Times Cited: 110
Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update
Pere Llinàs‐Arias, Manel Esteller
Open Biology (2017) Vol. 7, Iss. 9, pp. 170152-170152
Open Access | Times Cited: 81
Pere Llinàs‐Arias, Manel Esteller
Open Biology (2017) Vol. 7, Iss. 9, pp. 170152-170152
Open Access | Times Cited: 81
Characteristics ofDNMT3Amutations in acute myeloid leukemia
Dong Jin Park, Ahlm Kwon, Byung‐Sik Cho, et al.
Blood Research (2020) Vol. 55, Iss. 1, pp. 17-26
Open Access | Times Cited: 55
Dong Jin Park, Ahlm Kwon, Byung‐Sik Cho, et al.
Blood Research (2020) Vol. 55, Iss. 1, pp. 17-26
Open Access | Times Cited: 55
Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia
Satoshi Wakita, Atsushi Marumo, Kaoru Morita, et al.
Cancer Science (2023) Vol. 114, Iss. 4, pp. 1297-1308
Open Access | Times Cited: 17
Satoshi Wakita, Atsushi Marumo, Kaoru Morita, et al.
Cancer Science (2023) Vol. 114, Iss. 4, pp. 1297-1308
Open Access | Times Cited: 17
Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors
Eleonora Boscaro, Irene Urbino, Federica Maria Catania, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3512-3512
Open Access | Times Cited: 16
Eleonora Boscaro, Irene Urbino, Federica Maria Catania, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3512-3512
Open Access | Times Cited: 16
Prognostic impact of co-mutations in adults with IDH1/2-mutated acute myeloid leukemia
Anli Lai, Wenbing Liu, Chunlin Zhou, et al.
Blood Science (2025) Vol. 7, Iss. 2, pp. e00231-e00231
Open Access
Anli Lai, Wenbing Liu, Chunlin Zhou, et al.
Blood Science (2025) Vol. 7, Iss. 2, pp. e00231-e00231
Open Access
Alterations to DNMT3A in Hematologic Malignancies
Kartika Venugopal, Yang Feng, Daniil E. Shabashvili, et al.
Cancer Research (2020) Vol. 81, Iss. 2, pp. 254-263
Open Access | Times Cited: 29
Kartika Venugopal, Yang Feng, Daniil E. Shabashvili, et al.
Cancer Research (2020) Vol. 81, Iss. 2, pp. 254-263
Open Access | Times Cited: 29
The association of FAT1 mutations with therapeutic outcomes in AML, especially in receiving venetoclax combination
Tao Wang, Junxia Huang, Yongqian Jia, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Tao Wang, Junxia Huang, Yongqian Jia, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Cooperative genomic alteration network reveals molecular classification across 12 major cancer types
Hongyi Zhang, Yulan Deng, Yong Zhang, et al.
Nucleic Acids Research (2016) Vol. 45, Iss. 2, pp. 567-582
Open Access | Times Cited: 27
Hongyi Zhang, Yulan Deng, Yong Zhang, et al.
Nucleic Acids Research (2016) Vol. 45, Iss. 2, pp. 567-582
Open Access | Times Cited: 27
Decoding DNA methylation in epigenetics of multiple myeloma
Ting Yang, Xiaobo Liu, Shaji Kumar, et al.
Blood Reviews (2021) Vol. 51, pp. 100872-100872
Closed Access | Times Cited: 22
Ting Yang, Xiaobo Liu, Shaji Kumar, et al.
Blood Reviews (2021) Vol. 51, pp. 100872-100872
Closed Access | Times Cited: 22
Mutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance ofDNMT3Amutations
Sang-Yong Shin, Seung‐Tae Lee, Hee‐Jin Kim, et al.
Oncotarget (2016) Vol. 7, Iss. 34, pp. 54825-54837
Open Access | Times Cited: 23
Sang-Yong Shin, Seung‐Tae Lee, Hee‐Jin Kim, et al.
Oncotarget (2016) Vol. 7, Iss. 34, pp. 54825-54837
Open Access | Times Cited: 23
FLT3-ITD with DNMT3A R882 double mutation is a poor prognostic factor in Chinese patients with acute myeloid leukemia after chemotherapy or allogeneic hematopoietic stem cell transplantation
Shanhao Tang, Hongjie Shen, Xinliang Mao, et al.
International Journal of Hematology (2017) Vol. 106, Iss. 4, pp. 552-561
Closed Access | Times Cited: 22
Shanhao Tang, Hongjie Shen, Xinliang Mao, et al.
International Journal of Hematology (2017) Vol. 106, Iss. 4, pp. 552-561
Closed Access | Times Cited: 22
DNMT3A mutations in Chinese childhood acute myeloid leukemia
Weijing Li, Lei Cui, Chao Gao, et al.
Medicine (2017) Vol. 96, Iss. 31, pp. e7620-e7620
Open Access | Times Cited: 18
Weijing Li, Lei Cui, Chao Gao, et al.
Medicine (2017) Vol. 96, Iss. 31, pp. e7620-e7620
Open Access | Times Cited: 18
Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Xavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Haematologica (2017) Vol. 103, Iss. 2, pp. 256-265
Open Access | Times Cited: 18
Xavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Haematologica (2017) Vol. 103, Iss. 2, pp. 256-265
Open Access | Times Cited: 18
<p>Acute myeloid leukemia patient with <em>FLT3-ITD</em> and <em>NPM1</em> double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis </p>
Yan Huang, Juan Hu, Ting Lu, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 4129-4142
Open Access | Times Cited: 17
Yan Huang, Juan Hu, Ting Lu, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 4129-4142
Open Access | Times Cited: 17
Pattern of somatic mutation changes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes
Sanghee Hong, Lisa Rybicki, Carmelo Gurnari, et al.
Bone Marrow Transplantation (2022) Vol. 57, Iss. 10, pp. 1615-1619
Open Access | Times Cited: 9
Sanghee Hong, Lisa Rybicki, Carmelo Gurnari, et al.
Bone Marrow Transplantation (2022) Vol. 57, Iss. 10, pp. 1615-1619
Open Access | Times Cited: 9
FLT3-ITD compared with DNMT3A R882 mutation is a more powerful independent inferior prognostic factor in adult AML patients after Allogeneic Hematopoietic Stem Cell Transplantation: A retrospective cohort study
Majid Teremmahi Ardestani, Ahmad Kazemi, Bahram Chahardouli, et al.
Turkish Journal of Hematology (2018)
Open Access | Times Cited: 15
Majid Teremmahi Ardestani, Ahmad Kazemi, Bahram Chahardouli, et al.
Turkish Journal of Hematology (2018)
Open Access | Times Cited: 15
Comparison of the safety and efficacy of prophylactic donor lymphocyte infusion after haploidentical versus matched-sibling PBSCT in very high-risk acute myeloid leukemia
Xiaoning Gao, Ji Lin, Lijun Wang, et al.
Annals of Hematology (2019) Vol. 98, Iss. 5, pp. 1267-1277
Closed Access | Times Cited: 12
Xiaoning Gao, Ji Lin, Lijun Wang, et al.
Annals of Hematology (2019) Vol. 98, Iss. 5, pp. 1267-1277
Closed Access | Times Cited: 12
Clinical features and prognostic significance of DNMT3A, FLT3, and NPM1 mutations in de novo acute myeloid leukemia patients
Meiyu Chen, Zhao Zeng, Xuewei Li, et al.
International Journal of Laboratory Hematology (2023) Vol. 45, Iss. 6, pp. 899-907
Open Access | Times Cited: 4
Meiyu Chen, Zhao Zeng, Xuewei Li, et al.
International Journal of Laboratory Hematology (2023) Vol. 45, Iss. 6, pp. 899-907
Open Access | Times Cited: 4
FAT1 inhibits AML autophagy and proliferation via downregulating ATG4B expression
Nan Zhang, Meng-yu Shen, Qingli Meng, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1868, Iss. 1, pp. 130519-130519
Closed Access | Times Cited: 4
Nan Zhang, Meng-yu Shen, Qingli Meng, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1868, Iss. 1, pp. 130519-130519
Closed Access | Times Cited: 4
Association between increased mutation rates in DNMT3Α and FLT3‑ITD and poor prognosis of patients with acute myeloid leukemia
Qiurong Zhang, Xiao Wu, Jing Cao, et al.
Experimental and Therapeutic Medicine (2019)
Open Access | Times Cited: 11
Qiurong Zhang, Xiao Wu, Jing Cao, et al.
Experimental and Therapeutic Medicine (2019)
Open Access | Times Cited: 11